Ultrasound-guided 8-Gauge vacuum-assisted excision for selected B3 breast lesions: a preliminary experience
Tóm tắt
Nowadays, surgical excision is no longer justified for all B3 lesions and a minimally-invasive therapeutic treatment has been encouraged. The aim of this study was to evaluate the feasibility and the therapeutic efficacy of ultrasound-guided vacuum-assisted excision (US-VAE) for the treatment of selected breast lesions of uncertain malignant potential (B3). From July 2018 to December 2019, 11/48 breast lesions classified as B3 after ultrasound-guided core needle biopsy were treated with US-VAE in our Institution. Inclusion criteria were: B3 nodules ultrasonographically detectable for which VAE is recommended by international guidelines2, size ranging between 5 and 25 mm, circumscribed margins, and lesion position at least 5 mm from the skin and the nipple. A radiological follow-up to evaluate the completeness of excision, the presence of post-procedural hematoma or of residual disease/recurrence was performed after 10 and 30 days and 6 and 12 months. 12-month ultrasound was considered the gold standard. All patients were asked to complete a satisfaction survey and a full assessment of the costs of US-VAE was performed. Complete excision was achieved in 81.8% of US-VAE. No lesions were upgraded to carcinoma and no patients had to undergo surgery. No complications occurred during or after US-VAE. All patients were satisfied with the procedure and the cosmetic result (100%). US-VAE cost approximately 422 Euros per procedure. US-VAE has proven to be an optimal tool for the therapeutic excision of selected B3 lesions, with high success rate, good patient compliance and considerable money savings compared to surgery. This technique has the potential to reduce unnecessary surgery and healthcare costs.
Tài liệu tham khảo
HNSBCS and the Royal College of Pathologist guidelines for non-operative procedures and reporting in breast cancer screening (2017). https://www.rcpath.org/uploads/assets/4b16f19c-f7bd-456c-b212f557f8040f66/G150-Non-op-reporting-breast-cancer-screening-Feb17.pdf. Accessed 10 Feb 2021.
Rageth CJ, O’Flynn EAM, Pinker K et al (2019) Second international consensus conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 174:279–296. https://doi.org/10.1007/s10549-018-05071-1
Catanzariti F, Avendano D, Cicero G et al (2021) High-risk lesions of the breast: concurrent diagnostic tools and management recommendations. Insights Imaging 12(1):63. https://doi.org/10.1186/s13244-021-01005-6
Shaaban AM, Sharma N (2019) Management of B3 lesions-practical issues. Curr Breast Cancer Rep 11:83–88. https://doi.org/10.1007/s12609-019-0310-6
Documento di consenso sulle procedure diagnostiche preoperatorie nelle lesioni mammarie (2016) GISMa Gruppo Italiano Screening Mammografico.
Giannotti E, James JJ, Chen Y et al (2021) Effectiveness of percutaneous vacuum-assisted excision (VAE) of breast lesions of uncertain malignant potential (B3 lesions) as an alternative to open surgical biopsy. Eur Radiol. https://doi.org/10.1007/s00330-021-08060-z
Rakha EA, Lee AHS, Jenkins JA et al (2011) Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) abnormalities detected by mammographic screening. Int J Cancer 129:1417–1424. https://doi.org/10.1002/ijc.25801
Mayer S, Kayser G, Rucker G et al (2017) Absence of epithelial atypia in B3-lesions of the breast is associated with decreased risk of malignancy. Breast 31:144–149. https://doi.org/10.1016/j.breast.2016.11.007
Bennett IC (2017) The changing role of vacuum-assisted biopsy of the breast: a new prototype of minimally invasive breast surgery. Clin Breast Cancer 17:323–325. https://doi.org/10.1016/j.clbc.2017.03.001
Bennett IC, Saboo A (2019) The evolving role of vacuum assisted biopsy of the breast: a progression from fine-needle aspiration biopsy. World J Surg 43:1054–1061. https://doi.org/10.1007/s00268-018-04892-x
O’Flynn EA, Wilson AR, Michell MJ (2010) Image-guided breast biopsy: state-of-the-art. Clin Radiol 65:259–270. https://doi.org/10.1016/j.crad.2010.01.008
Pinder SE, Shaaban A, Deb R et al (2018) NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions). Clin Radiol 73:682–692. https://doi.org/10.1016/j.crad.2018.04.004
Salazar JP, Miranda I, de Torres J et al (2019) Percutaneous ultrasound-guided vacuum-assisted excision of benign breast lesions: a learning curve to assess outcomes. Br J Radiol 92:20180626. https://doi.org/10.1259/bjr.20180626
Rageth CJ, O’Flynn EA, Comstock C et al (2016) First international consensus conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 159:203–213. https://doi.org/10.1007/s10549-016-3935-4
Lucioni M, Rossi C, Lomoro P et al (2021) Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended? Eur Radiol 31:920–927. https://doi.org/10.1007/s00330-020-07161-5
Tennant SL, Evans A, Hamilton LJ et al (2008) Vacuum-assisted excision of breast lesions of uncertain malignant potential (B3)-an alternative to surgery in selected cases. Breast 17:546–549. https://doi.org/10.1016/j.breast.2008.08.005
Perretta T, Lamacchia F, Ferrari D et al (2020) Evaluation of ultrasound-guided 8-Gauge vacuum-assisted excision system for the removal of US-detectable breast lesions. Anticancer Res 40:1719–1729. https://doi.org/10.21873/anticanres.14125
Ko KH, Jung HK, Youk JH et al (2012) Potential application of ultrasound-guided vacuum-assisted excision for well-selected intraductal papillomas of the breast: single-institutional experiences. Ann Surg Oncol 19:908–913. https://doi.org/10.1245/s10434-011-2050-3
Lee SH, Kim EK, Kim MJ et al (2014) Vacuum-assisted breast biopsy under ultrasonographic guidance: analysis of a 10-year experience. Ultrasonography 33:259–266. https://doi.org/10.14366/usg.14020
Buğdaycı O, Kaya H, Arıbal E (2017) Ultrasound guided therapeutic excisional vacuum-assisted biopsy in breast fibroadenomas. J Breast Health 13:74–76. https://doi.org/10.5152/tjbh.2017.3038
Thurley P, Evans A, Hamilton L et al (2009) Patient satisfaction and efficacy of vacuum-assisted excision biopsy of fibroadenomas. Clin Radiol 64:381–385. https://doi.org/10.1016/j.crad.2008.09.013
Shang QJ, Li N, Zhang MK et al (2020) Ultrasound-guided vacuum-assisted excisional biopsy to treat benign phyllodes tumors. Breast 49:242–245. https://doi.org/10.1016/j.breast.2019.12.008
McMahon MA, Haigh I, Chen Y et al (2020) Role of vacuum-assisted excision in minimising overtreatment of ductal atypias. Eur J Radiol 131:109258. https://doi.org/10.1016/j.ejrad.2020.109258
Fine RE, Boyd BA, Whitworth PW et al (2002) Percutaneous removal of benign breast masses using a vacuum-assisted handheld device with ultrasound guidance. Am J Surg 184:332–336. https://doi.org/10.1016/s0002-9610(02)00951-0
Kim MJ, Park BW, Kim SI et al (2010) Long-term follow-up results for ultrasound-guided vacuum-assisted removal of benign palpable breast mass. Am J Surg 199:1–7. https://doi.org/10.1016/j.amjsurg.2008.11.037
Povoski SP, Jimenez RE (2007) A comprehensive evaluation of the 8-gauge vacuum-assisted Mammotome® system for ultrasound-guided diagnostic biopsy and selective excision of breast lesions. World J Surg Oncol 5:83. https://doi.org/10.1186/1477-7819-5-83
Alonso-Bartolome P, Vega-Bolıvar A, Torres-Tabanera M et al (2004) Sonographically-guided 11-G directional vacuum-assisted breast biopsy as an alternative to surgical excision: utility and cost study in probably benign lesions. Acta Radiol 45:390–396. https://doi.org/10.1080/02841850410005633
Park HL, Hong J (2014) Vacuum-assisted breast biopsy for breast cancer. Gland Surg 3:120–127. https://doi.org/10.3978/j.issn.2227-684X.2014.02.03